Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

6,036 public trials 1,280 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Completed

A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

NCT00002084

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Anus Diseases, +32 more
Locations
  • Univ of South Alabama Mobile, Alabama, United States
  • Univ of Arizona / Health Science Ctr Tucson, Arizona, United States
  • Combat Group Los Angeles, California, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
View all 46 locations
View Trial Details
Terminated

A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

NCT06039384

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Banner Md Anderson Cancer Center Greeley, Colorado, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Mary Crowley Cancer Research Centers McCrc Headquarters Dallas, Texas, United States
View all 14 locations
View Trial Details
Terminated

Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer

NCT05167409

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Rutgers Cancer insititute New Brunswick, New Jersey, United States
  • Inova Schar Cancer Institute Fairfax, Virginia, United States
View Trial Details
Terminated

A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

NCT05328908

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +18 more
Locations
  • Local Institution - 0044 Springdale, Arkansas, United States
  • Local Institution - 0012 Los Angeles, California, United States
  • Local Institution - 0117 Norwich, Connecticut, United States
  • Local Institution - 0025 Miami, Florida, United States
View all 139 locations
View Trial Details

Related conditions